Journal article icon

Journal article

Type 2 diabetes, thiazolidinediones, and cardiovascular risk.

Abstract:

Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently available, however recent concerns around cardiovascular safety have led to restrictions on their use. Initial trials showed treatments with glitazones improved glycaemic control, however long-term...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.3399/bjgp09x453440

Authors


Journal:
The British journal of general practice : the journal of the Royal College of General Practitioners
Volume:
59
Issue:
564
Pages:
520-524
Publication date:
2009-07-05
DOI:
EISSN:
1478-5242
ISSN:
0960-1643
URN:
uuid:592eae72-560e-4492-9b2e-0b19f089f38a
Source identifiers:
122512
Local pid:
pubs:122512

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP